Miron Hazani

Omega Life Science Ltd. develops aerosol drug delivery systems and equipment for API manufacturing and formulation. Its product Alphaze, is an inhaler platform that is positioned to replace the conventional way by which inhalable therapeutics and vaccinations are packaged, administered and marketed. The company was founded in January 2011 and is headquartered in Migdal Haemeq, Israel.

Omega Life Science Ltd. develops aerosol drug delivery systems and equipment for API manufacturing and formulation. Its product Alphaze, is an inhaler platform that is positioned to replace the conventional way by which inhalable therapeutics and vaccinations are packaged, administered and marketed. The company was founded in January 2011 and is headquartered in Migdal Haemeq, Israel.

Omega Life Science Ltd. develops aerosol drug delivery systems and equipment for API manufacturing and formulation. Its product Alphaze, is an inhaler platform that is positioned to replace the conventional way by which inhalable therapeutics and vaccinations are packaged, administered and marketed. The company was founded in January 2011 and is headquartered in Migdal Haemeq, Israel.

Omega Life Science Ltd. develops aerosol drug delivery systems and equipment for API manufacturing and formulation. Its product Alphaze, is an inhaler platform that is positioned to replace the conventional way by which inhalable therapeutics and vaccinations are packaged, administered and marketed. The company was founded in January 2011 and is headquartered in Migdal Haemeq, Israel.